Nom du produit:5-Bromo-2-fluoro-1,3-dimethylbenzene
IUPAC Name:5-bromo-2-fluoro-1,3-dimethylbenzene
- CAS：99725-44-7
- Formule moléculaire：C8H8BrF
- Pureté：95%+
- Numéro de catalogue：CM256101
- Poids moléculaire：203.05
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:99725-44-7
- Formule moléculaire:C8H8BrF
- Point de fusion:-
- Code SMILES:CC1=CC(Br)=CC(C)=C1F
- Densité:
- Numéro de catalogue:CM256101
- Poids moléculaire:203.05
- Point d'ébullition:205°C at 760 mmHg
- N° Mdl:MFCD01320701
- Stockage:Store at room temperature.
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Orforglipron
- Obesity is becoming an increasingly serious public health problem globally, plaguing millions of people and significantly increasing their risk of chronic diseases such as diabetes and heart disease. In recent years, with the approval of new weight loss drugs such as Wegovy (Semaglutide) and Mounjaro (Tirzepatide), people's attention to this field has once again heated up, spawning an upsurge in the research and development of new treatments. There are currently nearly 70 obesity treatments in the research and development stage. Eli Lilly's Orforglipron is the world's first oral small molecule GLP-1RA to start Phase III clinical trials.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
